Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), bought 20,000 shares at $0.76 ($15K) on 2012-06-29, disclosed to the SEC on 2012-07-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |
| ANTH | SELL | 2011-12-16 | $95K | — | Filing → |